On this limited data, either mechanical or chemical IOL in suspected IUGR/SGA is reasonable. However, a sizeable RCT specifically to answer the question of chemical versus mechanical IOL in this group, ± pooling of SGA subgroup data from general IOL trials, is required to provide definitive data. Objectives: To characterise lipid metabolomic changes in maternal and umbilical cord blood of pregnancies with sub-optimal fetal growth. Methods: Prospective cohort study in singleton term gestations including 27 normally grown newborns and 51 small fetuses classified into small for gestational age (SGA) (if birthweight 3rd-9th and had normal fetoplacental Doppler. n=27) and fetal growth restriction (FGR) (if birthweight <3rd centile and/or abnormal fetoplacental Doppler; n=24). Maternal and cord blood samples were analysed by 1 H-NMR and diffusion data assessed by targeted metabolomics to determine lipoprotein content, choline and glycoprotein compounds (Liposcale ® test). Results: Targeted lipidomics could clearly discriminate between the groups. Lipoprotein profiles showed significantly lower maternal concentrations of cholesterol-IDL (-17%), and triglycerides-IDL as well as -HDL in small fetuses (both, SGA and FGR) compared to controls (all p<0.05). While FGR fetuses had significant higher levels of cholesterol-VLDL (+56%). -IDL (+24%). triglycerides-VLDL (+24%) and -IDL (+18%) than controls (all p<0.005) (Figure) . Changes in phosphatidylcholines and glycoproteins were more prominent in FGR vs. controls, indicating significant alterations in their abundance and biophysical properties. Conclusions: These results provide a substantial understanding of the widespread disruption of lipid profiles in both maternal and cord blood of pregnancies with suboptimal fetal growth.
Supporting information can be found in the online version of this abstract OP13.08 Placental three-dimensional power Doppler indices in pregnancies complicated by gestational diabetes mellitus
C. Chen
Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan Objectives: To compare the effects of placental three-dimensional power Doppler indices and volume in pregnant women with gestational diabetes mellitus (GDM). Methods: This was a prospective case-control study of singleton pregnancies with risk factors for GDM. Data on placental vascular indices including vascularisation index (VI), flow index (FI), and vascularisation flow index (VFI), as well as placental volume were obtained and analysed during the first and second trimesters of pregnancies. Results: Of the 155 pregnant women enrolled, 31 developed GDM and 124 did not. VI and VFI were significantly lower in the GDM group during the first and second trimesters (VI: P = 0.023, and VFI: P = 0.014 in the first trimester; VI: P = 0.049, and VFI: P = 0.031 in the second trimester). However, the placental volume was similar in both groups during the first trimester, while it was significantly increased in the GDM group during the second trimester (P = 0.022). After adjustments in multivariate logistic regression analysis, significant differences were observed in the first trimester VFI (adjusted odds ratio (OR), 0.76 (95% CI, 0.61-0.93)), second trimester VFI (adjusted OR, 0.83 (95% CI, 0.71-0.96)), and second trimester placental volume (adjusted OR, 1.03 (95% CI, 1.01-1.05)). Conclusions: Placental VFI rather than volume may be a feasible sonographic marker in the first trimester to predict GDM.
Supporting information can be found in the online version of this abstract Objectives: To assess birthweight (BW) and intrauterine fetal growth patterns of pregnancies following bariatric surgery (BS) compared to pregnancies without BS. Methods: Pregnant women with previous BS (restrictive or malabsorptive procedure) and those without were recruited in the study. Fetal biometry, including head circumference (HC), abdominal circumference (AC), femur length (FL) and calculated estimated fetal weight (EFW) (Hadlock formula), was performed at 20-24, 30-32 and 35-37 weeks gestation using 2D ultrasound.
BW was modelled using a Bayesian normal linear regression model. Estimated differences in mean BW by BS group were calculated from this model, adjusting for gestational age at delivery, BMI, and GDM. Fetal growth parameters were also modelled using Bayesian hierarchical normal linear regression models. All analyses were conducted using Stan version 2.14 run via RStan in R version 3.3.2. Results: 36 women post-BS (16 restrictive and 20 malabsorptive procedure) and 93 women without BS were included in the study. Babies of mothers post BS had lower average BW than those of mothers without BS. Babies in the malabsorbtive surgery group were 268 g (90% CrI [64, 472] lighter on average than the no surgery group. Mean BW was also lower for the restrictive surgery group (200g, 425] ) and we found little evidence that BW differed between the two types of surgery. The BS group also had lower EFW on average than the no surgery group throughout gestation, from 16g lighter (95% CrI [1, 31] ) at 22 weeks, up to 89g lighter (95% CrI [5, 172] ) at 36 weeks. There was a small difference in AC, seen as early as 22 weeks, no difference in HC, HC/AC ratio and small difference in FL, which was driven by the malabsorbtive rather than the restrictive group. Conclusions: Birthweight was lower in the BS group compared to the no-surgery group. Fetuses in the former group were also lighter on average and this difference was seen as early as 22 weeks gestation. We found little evidence that EFW and BW differed between the two types of surgery.
